Wiltrom Co., Ltd. researches, develops, and produces a range of implantable medical devices. More Details
Flawless balance sheet with weak fundamentals.
Share Price & News
How has Wiltrom's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 6767 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 6767's weekly volatility (5%) has been stable over the past year.
7 Day Return
TW Medical Equipment
1 Year Return
TW Medical Equipment
Return vs Industry: 6767 underperformed the TW Medical Equipment industry which returned -5.9% over the past year.
Return vs Market: 6767 underperformed the TW Market which returned 48.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Wiltrom's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Wiltrom undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate 6767's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate 6767's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: 6767 is unprofitable, so we can't compare its PE Ratio to the TW Medical Equipment industry average.
PE vs Market: 6767 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6767's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6767's PB Ratio (2.1x) is in line with the TW Medical Equipment industry average.
How is Wiltrom forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wiltrom has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Wiltrom performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6767 is currently unprofitable.
Growing Profit Margin: 6767 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 6767 is unprofitable, and losses have increased over the past 5 years at a rate of 0.8% per year.
Accelerating Growth: Unable to compare 6767's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6767 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (9.9%).
Return on Equity
High ROE: 6767 has a negative Return on Equity (-0.57%), as it is currently unprofitable.
How is Wiltrom's financial position?
Financial Position Analysis
Short Term Liabilities: 6767's short term assets (NT$294.5M) exceed its short term liabilities (NT$26.5M).
Long Term Liabilities: 6767's short term assets (NT$294.5M) exceed its long term liabilities (NT$17.2M).
Debt to Equity History and Analysis
Debt Level: 6767 is debt free.
Reducing Debt: 6767 had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6767 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6767 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 31.6% each year
What is Wiltrom current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 6767's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 6767's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 6767's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 6767's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 6767's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
Wiltrom has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.3%.
Wiltrom Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Wiltrom Co., Ltd.
- Ticker: 6767
- Exchange: TPEX
- Founded: NaN
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: NT$852.894m
- Shares outstanding: 29.11m
- Website: https://www.wiltrom.com.tw
- Wiltrom Co., Ltd.
- No.26, Shengyi Road
- 1st Floor
Wiltrom Co., Ltd. researches, develops, and produces a range of implantable medical devices. Its products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body a...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/18 09:11|
|End of Day Share Price||2021/06/17 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.